DCM
LLY icon

Deuterium Capital Management’s Eli Lilly LLY Stock Holding History

Deuterium Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,803
Closed -$660K – 98
2022
Q4 		$660K Buy
1,803
+870
+93% +$308K 1.75% 13
2022
Q3 		$302K Sell
933
-926
-50% -$293K 1.26% 18
2022
Q2 		$603K Hold
1,859
– – 2.04% 10
2022
Q1 		$532K Buy
+1,859
New +$478K 0.68% 27

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deuterium Capital Management's LLY Position: Q1 2023 in Review

Deuterium Capital Management sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 1,803 shares — an estimated $660K sold.

Deuterium Capital Management first reported a position in LLY in Q1 2022 and held it in 4 quarters. The position peaked at $660K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Deuterium Capital Management reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 1,803 Eli Lilly shares in Q1 2023, an estimated $660K.
  • Deuterium Capital Management first reported a position in Eli Lilly in Q1 2022 and held it in 4 quarters.
  • Deuterium Capital Management's Eli Lilly position peaked at $660K in Q4 2022.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Deuterium Capital Management's 13F filing for Q1 2023, filed 12 May 2023.